Skip to main content
. 2019 Jun 11;121(2):109–116. doi: 10.1038/s41416-019-0481-y

Fig. 1.

Fig. 1

Management of hypertension before and during bevacizumab therapy. aABPM/HBPM recorded over at least 4 consecutive days. bIf there is a marked difference between clinic BP and ABPM/HBPM (i.e., >20/10 mmHg), the latter should be repeated with a treatment target of <150/95 mmHg. ABPM ambulatory blood pressure monitoring, BP blood pressure, HBPM home blood pressure monitoring, n/a not applicable, NICE National Institute for Health and Care Excellence